National Intellectual Property Law Firm Brinks Gilson & Lione Adds Five to Growing Practice in BioPharma
Four Attorneys, Patent Agent Join Firm in Research Triangle Park, N.C.
RESEARCH TRIANGLE PARK, N.C.— Brinks Gilson & Lione, one of the nation’s largest intellectual property law firms, today announced that four attorneys and one patent agent are joining its life sciences group in Research Triangle Park, N.C.(RTP) —doubling the size of the firm's RTP office and creating one of the largest intellectual property teams in the Southeastern US able to serve clients in the biotechnology, pharmaceutical, chemical, and agricultural sectors.
“Brinks is committed to expanding its capabilities in key areas where our clients are investing in innovation,” said James R. Sobieraj, the firm’s president, on announcing the arrival of the new lawyers and patent agent. “Pharmaceutical and biotechnology companies in particular require that outside counsel deeply understand the scientific and legal issues specific to these industries. Brinks specializes in these highly complex areas.”
Amy H. Fix, formerly in-house patent counsel at global pharmaceutical company GlaxoSmithKline and a specialist in providing strategic advice in pharmaceutical intellectual property issues, is the senior attorney in the group. Fix is joined by attorneys Mark David Jenkins, Bernard A. Brown, II, Ph.D., and Aisha R. Hasan. In addition, Bryan T. Richardson, Ph.D., joins the firm as a patent agent. All five formerly were colleagues at the law firm of Womble Carlyle Sandridge & Rice LLP.
'I'm delighted to welcome our new colleagues, who have superb credentials and experience in IP law in addition to outstanding educational and professional credentials in life science disciplines,' said Allen R. Baum, managing shareholder of Brinks' Research Triangle Park office. “We are committed to continuing to grow our presence in North Carolina and the Southeast.”
'This strengthening of our team allows us to offer even greater capabilities in specialized areas like Hatch-Waxman and Biologics Price Competition and Innovation Act (BPCIA) matters for small-molecule and biologic drugs to our clients regionally and nationally,' added Baum.
Brinks established its Research Triangle Park office in 2008. The attorneys in Brinks’ Research Triangle Park and other nationwide offices serve clients from start-ups to multinational corporations based domestically and internationally.
Bernard A. Brown, II, Ph.D., is a patent attorney and former biochemistry professor who uses his extensive research background to guide chemical, pharmaceutical, and biotechnology clients in patent matters. His practice includes patent prosecution; reexamination requests; patentability, freedom-to-operate, and prior art searches; invalidity and non-infringement opinions; and Hatch-Waxman and BPCIA analyses. Before becoming an attorney, Dr. Brown was an assistant professor of biochemistry and chemistry at Wake Forest University. He has authored more than 20 scientific articles and book chapters, and holds a patent related to generating monoclonal antibodies that recognize multi-stranded DNA complexes. Brown earned his Ph.D. in biochemistry at North Carolina State University, where he earlier earned a B.A. in chemistry and B.S. degrees in zoology and biochemistry. He completed a postdoctoral fellowship in structural biology at Massachusetts Institute of Technology and earned his J.D. from Elon University School of Law.
Amy H. Fix brings more than 16 years of experience in both in-house and outside counsel roles to her work as a patent attorney for clients with innovations in the chemical arts. Her background as in-house patent counsel at pharmaceutical company GlaxoSmithKline and at Targacept, Inc., a biopharmaceutical firm, helps her appreciate the client's perspective and underlies her business-oriented approach to patent matters, in particular those involving drugs and other therapies related to small molecule compounds. Fix graduated cum laude with a B.S. in chemistry from North Carolina State University; she earned her J.D. from Campbell University's Norman Adrian Wiggins School of Law.
Aisha R. Hasan is a patent attorney who assists clients in the fields of biochemistry, chemistry, immunology, molecular biology, agricultural biotechnology, and pharmaceuticals. Her practice includes preparing and prosecuting U.S. and foreign patent applications and conducting patentability, freedom-to-operate, and prior art searches. Hasan previously worked as a scientist doing research in biophysical chemistry, peptide synthesis, oligonucleotide synthesis, structural biology, microbiology, and virology. Hasan earned a B.S. in biology from George Mason University and a M.S. in biochemistry and molecular biology from The George Washington University. She earned her J.D. cum laude at the North Carolina Central University School of Law.
Mark David Jenkins is a patent attorney with a professional background as a chemist. He provides guidance on IP strategy for clients in the chemical and biotechnology industry sectors, and prosecutes patents in both the U.S. and abroad. Jenkins also has experience in conducting reexaminations, patent due diligence reviews, freedom-to-operate analyses, and validity analyses. Prior to entering the legal field, Jenkins worked as a product development chemist for a global absorbent product design company, and as an analytical chemist in the pharmaceutical division of a major healthcare corporation. He graduated summa cum laude with a B.S. in chemistry from the University of Tennessee, earned an M.S. in chemistry from Vanderbilt University, and earned his J.D. cum laude at the Franklin Pierce Law Center at the University of New Hampshire.
Bryan T. Richardson, Ph.D., helps clients in the biotechnology, medical, biochemical, and pharmaceutical fields prepare, prosecute, and protect life sciences patents. He also performs patentability, freedom-to-operate, and prior art searches, and assists with patent-related due diligence in mergers and acquisitions and in joint development, licensing, and valuation situations. Dr. Richardson earned his B.S. in biology summa cum laude at East Carolina University, and his Ph.D. in pharmacology at the University of North Carolina.
Brinks Gilson & Lione
The attorneys, scientific advisors and patent agents at Brinks Gilson & Lione practice exclusively in the field of intellectual property, making Brinks one of the largest intellectual property law firms in the U.S. Clients around the world use Brinks to help them protect and enforce their intellectual property rights. Brinks lawyers provide counseling in all aspects of patent, trademark, unfair competition, trade secret and copyright law. More information is at www.brinksgilson.com.